Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will be participating in three
conferences during September. On September 3, 2013, Infinity will
participate in meetings at Citi’s 8th Annual Biotech
Conference in Boston, MA. Additionally, Infinity will provide an
overview of its business at the following conferences:
Live audio webcasts of Infinity’s presentations at the Morgan Stanley
and Stifel healthcare conferences will be accessible from the
“Investors/Media” section of the company's website, www.infi.com,
and replays will be available for 30 days following each event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative biopharmaceutical company dedicated to
discovering, developing and delivering best-in-class medicines to people
with difficult-to-treat diseases. Infinity combines proven scientific
expertise with a passion for developing novel small molecule drugs that
target emerging disease pathways. Infinity’s programs focused on the
inhibition of phosphoinositide-3-kinase and heat shock protein 90 are
evidence of its innovative approach to drug discovery and development.
For more information on Infinity, please refer to the company’s website
at www.infi.com.
![](http://cts.businesswire.com/ct/CT?id=bwnews&sty=20130827005032r1&sid=ntxv4&distro=nx)
Copyright Business Wire 2013